Results 181 to 190 of about 261,869 (302)

Studies on influenza vaccine in industry

open access: green, 1973
J. W. G. Smith, Richard B. Pollard
openalex   +1 more source

The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways

open access: yesSmall, EarlyView.
Lipid nanoparticles are vital for drug delivery, but their cellular interactions remain unclear. This study shows that non‐lamellar lyotropic liquid crystalline nanoparticles (LLCNPs) ‐ including cubosomes, hexosomes, and micellar cubosomes ‐ preferentially use passive pathways like membrane fusion, bypassing endocytic recycling faced by lamellar ...
Sue Lyn Yap   +7 more
wiley   +1 more source

Bioactive Polysulfate‐Based Nano‐Assemblies Against Virus Infection

open access: yesSmall, EarlyView.
Nano‐assemblies with a defined brush‐like corona are developed from sulfated polyglycerol to inhibit virus infection. The sulfate residues on the surface can actively bind the virus and entrap it from entering the host cells. This nanosystem is demonstrated potent inhibition against both HSV‐1 and SARs‐CoV‐2.
Guoxin Ma   +9 more
wiley   +1 more source

Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses. [PDF]

open access: yesEmerg Microbes Infect
Huang CQ   +13 more
europepmc   +1 more source

Understanding of endo/lysosomal escape of nanomaterials in biomedical application

open access: yesSmart Molecules, EarlyView.
This review summarized mainstream mechanisms of endo/lysosomal escape and design strategies of endo/lysosomal escapable nanoparticles in view of surface charge, polarity & hydrophobicity, particle morphology, and lysosomal escape agents. The utilization of endo/lysosomal escapable nanoparticles for vaccine delivery and genetic engineering are ...
Xin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy